During exercise, cardiac oxygen consumption increases and the resulting low oxygen level in the myocardium triggers coronary vasodilation. This response to hypoxia is controlled notably by the vasodilator adenosine and its A 2A receptor (A 2A R). According to the "spare receptor" pharmacological model, a strong A 2A R-mediated response can occur in the context of a large number of receptors remaining unoccupied, the activation of only a weak fraction of A 2A R (evaluated using K D ), which results in maximal cAMP production (evaluated using EC 50 ), and hence in maximal coronary vasodilation. In coronary artery disease (CAD), myocardial ischemia limits adaptation to exercise, which is commonly detected using the exercise stress test (EST). We hypothesized that spare A 2A R is present in CAD patients to correct ischemia. Seventeen patients with angiographically documented CAD and 17 control subjects were studied. We addressed adenosine-plasma concentration and A 2A R-expression at the mononuclear cell-surface, which reflects cardiovascular expression. The presence of spare A 2A R was tested using an innovative pharmacological approach based on a homemade monoclonal antibody with agonist properties. EST was positive in 82% of patients and in none of the controls. Adenosine plasma concentration increased by 60% at peak exercise in patients and in none of the controls (p < 0.01). Most patients (65%), and none of the controls, had spare A 2A R (identified when EC 50 /K D ≤ 0.1) and a low A 2A R-expression (mean: -37% versus controls; p < 0.01). All patients with spare A 2A R had a positive EST whereas the subjects without spare A 2A R had a negative EST (p < 0.05). Spare A 2A R is therefore associated with positive EST in CAD patients and its detection may be used as a diagnostic marker.
Sometimes a strong A 2A R-mediated response occurs in the context of a large reserve of unoccupied receptors called "spare receptors" according to the Stephenson's receptor theory (12) . The presence of spare A 2A R is evidenced when activation of only a weak fraction of A 2A R (evaluated using the K D variable) results in maximal cAMP production (evaluated using the EC 50 variable), and hence in maximal coronary vasodilation (13) (14) (15) . Thus, the presence of spare A 2A R allows for rapid, transient responses that are sensitive to low agonist concentrations. In other words, the presence of spare A 2A R is expected to provide a high-efficiency vasodilation mechanism.
In coronary artery disease (CAD), the vasodilatory response to myocardial the vasodilator adenosine that regulates coronary blood flow, in particular via activation of the adenosine A 2A receptor (A 2A R), and coupling to the cAMP pathway (2) (3) (4) (5) (6) (7) (8) (9) (10) . Cyclic AMP production and coronary vasodilation are correlated (11) .
INTRODuCTION
During muscle exercise, heart work and the resulting myocardial energetic consumption increase. The ensuing low oxygen level in the myocardium triggers coronary vasodilation (1) 3 Nathalie Kipson, 1 Giovanna Mottola, 1 Julien Fromonot, 1, 4 Jocelyne Condo, 1 Alain Boussuges, 1 Laurie Bruzzese, 1 François Kerbaul, 5 Yves Jammes, 1 Vlad Gariboldi, 6 Frédéric Franceschi, 1 Emmanuel Fenouillet, 1, 7 and Régis Guieu was considered to be significant if the stenosis was ≥ 70% in a major coronary artery. The treatment of the patients was conservative.
EST Procedure
The treadmill test was symptomlimited and was terminated if the patient had exercise-limiting chest pain, shortness of breath or other symptoms 7 women; mean age, 60 years [37-69]) with no history of CAD and who underwent cardiac examination prior to plastic surgery were included as controls. The patients in the control group underwent voluntary coronary computed tomography angiography (CCTA) evaluation and EST. The coronary arteries were assessed using the 17-segment AHA model. Disease of the epicardial coronary arteries hypoxia appears to be generally unable to correct myocardial ischemia that is detected using the exercise stress test (EST) (1) . The presence of spare A 2A R in CAD patients and its role in CAD pathophysiology in which the regulation of myocardial blood flow is altered have never been addressed, and we hypothesized that spare A 2A R is present in CAD patients to try to correct myocardial ischemia. We therefore undertook in this study to test the pharmacological characteristics of A 2A R present on peripheral blood mononuclear cells (PBMC) because i) this cell population is readily accessible compared with coronary tissues and ii) properties of A 2A R on PBMC appear to be similar to those of A 2A R in heart tissue as changes in PBMC-surface expression of A 2A R occur in cardiovascular diseases are associated with adenosine metabolism abnormalities (16) (17) (18) , which suggests that regulation of A 2A R expression may be a systemic mechanism.
MATERIALS AND METHODS

Compliance with Ethical Standards
The protocol was approved by the Ethics Committee of our institution (CPP Sud Méditerranée, Marseille, France). The study conformed to the standards set out in the 1983 Declaration of Helsinki. Written informed consent to participate in the study was obtained for all subjects.
Study Population
Seventeen patients (11 men and 6 women; mean age/range, 64 years [40-80]) with angiographically documented CAD were consecutively enrolled in the study as part of their medical follow-up, which included exercise stress testing (EST) ( Table 1 ): i) 8 subjects were previously revascularized and EST was performed to determine the incidence of restenosis due to symptoms such as dyspnea and angina pectoris; ii) 5 type-2 diabetic subjects were screened for silent myocardial ischemia; and iii) 4 subjects with a suspicion of CAD were subjected to EST. Seventeen control patients (10 men and (14, 15) , with only the kappa light chain (25 kDa) being stained here using specific peroxidase-labeled antibodies and chemiluminescent substrate. The staining intensity was measured using densitometry analysis and expressed as AU (that is, the ratio of pixels generated by the light chain band to pixels generated by the background signal). K D values for Adonis binding were estimated using nonlinear regression analysis (Prism software; GraphPad Software). cAMP dosage (EC 50 ). We undertook to address the cAMP production level induced by incubation of increasing concentrations of the agonist-like Adonis with PBMC (0.75 × 10 6 cells) using the Amersham Biotrak Kit (GE Healthcare Bio-Sciences). Dodecyltrimethylammonium bromide acetate buffer was used to stop the incubation step. Two independent experiments with triplicates were performed and results expressed as the percentage of the maximal cAMP production. EC 50 was defined as the concentration of Adonis that leads to half maximal stimulation of cAMP production (24, 25) . Identification of the presence of spare A 2A R. A spare A 2A R mechanism was identified when the EC 50 /K D ratio ≤ 0.1 (25) . from the brachial vein were collected in tubes containing sodium citrate, a polyester gel and a density gradient liquid (Vacutainer CPT, Beckton Dickinson). Blood samples were then centrifuged (20 min; 1,700g at room temperature), and the PBMC layer was collected and washed twice using phosphate-buffered saline prior to treatment with lysis buffer and sonication. Samples (equivalent to 0.25 × 10 6 cells) were then submitted to standard 12% polyacrylamide gel electrophoresis under reducing conditions followed by transfer onto a PVDF membrane. The filter was then incubated with Adonis (1 μg/mL), a homemade IgM, κ mouse monoclonal antibody directed against a linear epitope on A 2A R (23), and staining was performed using horseradish peroxidase-labeled anti-mouse antibodies and enhanced chemiluminescence substrate. The 45-kDa bands corresponding to A 2A R were submitted to densitometry analysis using the ImageJ 1.42q software (National Institutes of Health) and results were expressed as arbitrary units (AU), the ratio of pixels generated by the A 2A R band to pixels generated by the background signal.
Identification of Spare A 2A R Adonis is an agonist-like monoclonal antibody that binds with an high affinity linear epitope localized in the second extracellular loop of the human A 2A R (23) . Consequently: i) Adonis behaves as an irreversible ligand of A 2A R, at least during the length of the experiment, irreversible binding being necessary for the pharmacological identification of spare receptors (13) ; ii) Adonis similarly recognizes various forms of A 2A R expressed on cells; iii) Adonis binds to the PBMC surface triggering cAMP production (23) . Therefore, Adonis allows determination of both binding (K D ) and functional (EC 50 ) parameters of A 2A R (24, 25) . For both analyses, PBMC were prepared using the vacutainer CPT system as described above and incubated with increasing concentrations of Adonis (0-1.8 μmol/L in 0.5-mL culture medium; 90 min; room temperature with shaking).
as assessed by the supervising clinician independently of the heart rate level. In accordance with the American Heart Association and the American College of Cardiology guidelines, testing could be terminated early at the discretion of the supervising clinician for significant arrhythmias, abnormal hemodynamic responses, ST-segment changes or if the participant was unwilling or unable to continue. Patients with baseline ECG abnormalities that could interfere with the interpretation of the criteria described above did not enter the study. Maximum heart rate level was assessed according to the formula: 220 -age. The bicycle ergometer was used in a sitting position (19) . Increments were of 30 watts/3-min stage starting from a base of 30 watts. Results were expressed in terms of maximum watts and metabolic equivalents of task level (MET) based on the workload derived from the maximal speed and grade achieved during the total treadmill time. The EST was considered positive when the patient developed ECG signs of ischemia (significant ST segment/T wave changes/downsloping ( > 2 mm) or horizontal ST-segment depression) and/or typical chest pain.
Adenosine Measurement
Blood samples (3 mL) were collected during a routine medical examination and processed as described previously using laboratory-prepared tubes containing 2 mL of a cold stop solution under vacuum. This method allows whole blood to mix quickly with the stop solution, thus preventing red blood cell uptake and adenosine degradation (20) (21) (22) . After collection, samples were centrifuged and deproteinized prior to analysis using high-performance liquid chromatography. Adenosine was identified by its elution time and spectrum and quantified by comparison of peak areas with those of known quantities of adenosine.
A 2A R Expression on PBMC
The procedure has been described previously (14, 15) . In brief, blood samples Western blot analysis of cell lysates and probing with the anti-A 2A R monoclonal antibody Adonis prior to densitometry analysis of the 45-kDa band. At the basal state, A 2A R expression was 37% lower in positive EST were distinguished from those with negative EST and the results are presented in Table 2 . A 2A R expression in PBMC isolated from patients and control subjects was investigated using
Statistical Analysis
Quantitative variables are expressed as means and standard deviations (SD) or range, or as medians and interquartile range (IQR). Variance analysis (two-way ANOVA) was used for intergroup comparisons. The Wilcoxon test was used to address adenosine plasma concentration kinetic. All statistical tests were twosided. Analyses were performed with the Prism software.
RESuLTS
Population of the Study
The subjects were consecutively enrolled. There was no significant difference in age between patients and controls (P > 0.05). The control subjects had a normal (without plaque) CCTA and a calcium score < 100. Angiographically documented CAD patients and controls were not matched for cardiovascular risk factors because all controls had normal CCTA. The clinical characteristics of the population and the treatments are given in Table 1 . We found that 14/17 (82%) patients had a positive EST (ECG signs of ischemia and/or painful ischemia) and that the 17 (100%) controls had a negative EST. The occurrence of signs of myocardial ischemia was significant in these patients because 10/17 patients had left main or left anterior descending artery disease, and hence a significant amount of myocardium particularly prone to ischemia during EST. CAD patients, such an EC 50 /K D ratio ≤ 0.1 is consistent with the presence of spare receptors (26) . Finally, we observed that all patients with spare A 2A R had a positive EST. Thus, we concluded that the presence of spare A 2A R is associated with signs of myocardial ischemia during exercise.
agonist and monitored here via cAMP production) was significantly lower in patients. More importantly, while EC 50 was greater than K D in healthy subjects, the reverse situation was found for patients: EC 50 was 10-fold lower than K D in 65% of the patients, and in 79% of patients with positive EST. In most (The analysis of EST-positive and EST-negative patients is shown in Table 2 
DISCuSSION
We have recently reported (27) that patients with positive exercise stress test have a low expression of A 2A R in the basal state and an increase in adenosine plasma concentration during EST, which is confirmed here. Although it is known that A 2A R expression increases in hypoxic/ischemic conditions (2), we considered that it would be pointless to attempt to highlight here a putative ischemia-induced adaptive increase in A 2A R expression during EST because the duration of the test is < 10 min in our patients, which is well below the time needed by the de novo synthesis and cell surface expression of A 2A R (28) .
Considering that spare A 2A R may be chronically present in CAD patients to try to correct myocardial ischemia in a context of low A 2A R expression and high exercise-induced adenosine concentration (27 and Figure 1) , we undertook to characterize the pharmacological properties of A 2A R in CAD. We observed that these properties differed between CAD patients and healthy subjects. While the K D for A 2A R of the agonist used here to mimic adenosine was similar in patients and controls, the EC 50 value (related to the biological effect triggered by the Spare A 2A R was first observed in guinea pig cardiac tissue using an irreversible A 2A R antagonist to block response to various agonists (13) . Here, we used an agonist-like monoclonal antibody and provided further evidence for the presence of spare A 2A R on the surface of human mononuclear cells in relation to cardiac dysfunction, spare A 2A R having already been observed in a context of neurocardiogenic syncope, but not in healthy subjects (14, 15, 18) .
It would have been expected that the presence of spare A 2A R would increase coronary blood flow in CAD patients as it would in an animal model, where an activation of only 5% of A 2A R present in the coronary system was sufficient to produce 50% of the maximal coronary conductance (13) . Yet, our results suggest that during EST, CAD patients with spare A 2A R failed to adjust coronary vasodilation to workload as shown by chest pain and/or ST depression at peak exercise. We concluded that in healthy subjects, the regulation of coronary vasodilation does not imply spare A 2A R, receptor expression and adenosine concentration being sufficient to accommodate the increased workload (27 and Figure 1 ). In contrast, in CAD patients with positive EST, the presence of spare A 2A R is not sufficient to provide efficient vasodilation during exercise in a context of low A 2A R expression level and despite an increase in adenosine plasma concentration. Another apparent paradox is that spare A 2A R that constitutes a reserve of receptors was detected in patients in which receptor expression was low. Whether the presence of spare A 2A R is an adaptive response in CAD patients to chronic myocardial ischemia or results from genetic predisposition needs further investigations.
CONCLuSION
These results show that the presence of spare A 2A R is associated with positive EST in CAD patients. Consequently, detecting spare A 2A R in the screening of CAD appears to be a promising diagnostic tool.
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